<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-06" modified="2017-03-15" version="154">
<accession>Q16644</accession>
<accession>B5BU67</accession>
<name>MAPK3_HUMAN</name>
<protein>
<recommendedName>
<fullName>MAP kinase-activated protein kinase 3</fullName>
<shortName>MAPK-activated protein kinase 3</shortName>
<shortName>MAPKAP kinase 3</shortName>
<shortName>MAPKAP-K3</shortName>
<shortName>MAPKAPK-3</shortName>
<shortName>MK-3</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Chromosome 3p kinase</fullName>
<shortName>3pK</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">MAPKAPK3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="8488" last="8492">
<title>Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase.</title>
<authorList>
<person name="McLaughlin M.M."/>
<person name="Kumar S."/>
<person name="McDonnell P.C."/>
<person name="Van Horn S."/>
<person name="Lee J.C."/>
<person name="Livi G.P."/>
<person name="Young P.R."/>
</authorList>
<dbReference type="PubMed" id="8626550"/>
<dbReference type="DOI" id="10.1074/jbc.271.14.8488"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="868" last="876">
<title>3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region.</title>
<authorList>
<person name="Sithanandam G."/>
<person name="Latif F."/>
<person name="Duh F.-M."/>
<person name="Bernal R."/>
<person name="Smola U."/>
<person name="Li H."/>
<person name="Kuzmin I."/>
<person name="Wixler V."/>
<person name="Geil L."/>
<person name="Shrestha S."/>
<person name="Lloyd P.A."/>
<person name="Bader S."/>
<person name="Sekido Y."/>
<person name="Tartof K.D."/>
<person name="Kashuba V.I."/>
<person name="Zabarovsky E.R."/>
<person name="Dean M."/>
<person name="Klein G."/>
<person name="Lerman M.I."/>
<person name="Minna J.D."/>
<person name="Rapp U.R."/>
<person name="Allikmets R."/>
</authorList>
<dbReference type="PubMed" id="8622688"/>
<dbReference type="DOI" id="10.1128/MCB.16.3.868"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION BY MAPK1/ERK2 AND MAPK3/ERK1</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="1880" last="1880">
<authorList>
<person name="Sithanandam G."/>
<person name="Latif F."/>
<person name="Duh F.-M."/>
<person name="Bernal R."/>
<person name="Smola U."/>
<person name="Li H."/>
<person name="Kuzmin I."/>
<person name="Wixler V."/>
<person name="Geil L."/>
<person name="Shrestha S."/>
<person name="Lloyd P.A."/>
<person name="Bader S."/>
<person name="Sekido Y."/>
<person name="Tartof K.D."/>
<person name="Kashuba V.I."/>
<person name="Zabarovsky E.R."/>
<person name="Dean M."/>
<person name="Klein G."/>
<person name="Lerman M.I."/>
<person name="Minna J.D."/>
<person name="Rapp U.R."/>
<person name="Allikmets R."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Colon</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1996" name="FEBS Lett." volume="392" first="209" last="214">
<title>A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress.</title>
<authorList>
<person name="Clifton A.D."/>
<person name="Young P.R."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="8774846"/>
<dbReference type="DOI" id="10.1016/0014-5793(96)00816-2"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF HSPB1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="18947" last="18956">
<title>Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation.</title>
<authorList>
<person name="Rogalla T."/>
<person name="Ehrnsperger M."/>
<person name="Preville X."/>
<person name="Kotlyarov A."/>
<person name="Lutsch G."/>
<person name="Ducasse C."/>
<person name="Paul C."/>
<person name="Wieske M."/>
<person name="Arrigo A.P."/>
<person name="Buchner J."/>
<person name="Gaestel M."/>
</authorList>
<dbReference type="PubMed" id="10383393"/>
<dbReference type="DOI" id="10.1074/jbc.274.27.18947"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HSPB1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="20239" last="20242">
<title>Serine/Threonine kinases 3pK and MAPK-activated protein kinase 2 interact with the basic helix-loop-helix transcription factor E47 and repress its transcriptional activity.</title>
<authorList>
<person name="Neufeld B."/>
<person name="Grosse-Wilde A."/>
<person name="Hoffmeyer A."/>
<person name="Jordan B.W."/>
<person name="Chen P."/>
<person name="Dinev D."/>
<person name="Ludwig S."/>
<person name="Rapp U.R."/>
</authorList>
<dbReference type="PubMed" id="10781029"/>
<dbReference type="DOI" id="10.1074/jbc.C901040199"/>
</citation>
<scope>INTERACTION WITH TCF3</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Exp. Cell Res." volume="299" first="101" last="109">
<title>Mitogen-activated 3p kinase is active in the nucleus.</title>
<authorList>
<person name="Zakowski V."/>
<person name="Keramas G."/>
<person name="Kilian K."/>
<person name="Rapp U.R."/>
<person name="Ludwig S."/>
</authorList>
<dbReference type="PubMed" id="15302577"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2004.05.027"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="5178" last="5187">
<title>MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1.</title>
<authorList>
<person name="Voncken J.W."/>
<person name="Niessen H."/>
<person name="Neufeld B."/>
<person name="Rennefahrt U."/>
<person name="Dahlmans V."/>
<person name="Kubben N."/>
<person name="Holzer B."/>
<person name="Ludwig S."/>
<person name="Rapp U.R."/>
</authorList>
<dbReference type="PubMed" id="15563468"/>
<dbReference type="DOI" id="10.1074/jbc.M407155200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-73</scope>
<scope>INTERACTION WITH PHC2 AND BMI1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Biochem. J." volume="409" first="711" last="722">
<title>Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex.</title>
<authorList>
<person name="Mendoza H."/>
<person name="Campbell D.G."/>
<person name="Burness K."/>
<person name="Hastie J."/>
<person name="Ronkina N."/>
<person name="Shim J.H."/>
<person name="Arthur J.S."/>
<person name="Davis R.J."/>
<person name="Gaestel M."/>
<person name="Johnson G.L."/>
<person name="Ghosh S."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="18021073"/>
<dbReference type="DOI" id="10.1042/BJ20071149"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TAB3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Biochem. Pharmacol." volume="80" first="1915" last="1920">
<title>MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin.</title>
<authorList>
<person name="Ronkina N."/>
<person name="Menon M.B."/>
<person name="Schwermann J."/>
<person name="Tiedje C."/>
<person name="Hitti E."/>
<person name="Kotlyarov A."/>
<person name="Gaestel M."/>
</authorList>
<dbReference type="PubMed" id="20599781"/>
<dbReference type="DOI" id="10.1016/j.bcp.2010.06.021"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Front. Biosci." volume="13" first="5511" last="5521">
<title>MK2 and MK3--a pair of isoenzymes?</title>
<authorList>
<person name="Ronkina N."/>
<person name="Kotlyarov A."/>
<person name="Gaestel M."/>
</authorList>
<dbReference type="PubMed" id="18508601"/>
<dbReference type="DOI" id="10.2741/3095"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2016" name="Hum. Mol. Genet." volume="25" first="916" last="926">
<title>A dominant mutation in MAPKAPK3, an actor of p38 signaling pathway, causes a new retinal dystrophy involving Bruch's membrane and retinal pigment epithelium.</title>
<authorList>
<person name="Meunier I."/>
<person name="Lenaers G."/>
<person name="Bocquet B."/>
<person name="Baudoin C."/>
<person name="Piro-Megy C."/>
<person name="Cubizolle A."/>
<person name="Quiles M."/>
<person name="Jean-Charles A."/>
<person name="Cohen S.Y."/>
<person name="Merle H."/>
<person name="Gaudric A."/>
<person name="Labesse G."/>
<person name="Manes G."/>
<person name="Pequignot M."/>
<person name="Cazevieille C."/>
<person name="Dhaenens C.M."/>
<person name="Fichard A."/>
<person name="Ronkina N."/>
<person name="Arthur S.J."/>
<person name="Gaestel M."/>
<person name="Hamel C.P."/>
</authorList>
<dbReference type="PubMed" id="26744326"/>
<dbReference type="DOI" id="10.1093/hmg/ddv624"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INVOLVEMENT IN MDPT3</scope>
<scope>VARIANT MDPT3 PRO-173</scope>
<scope>CHARACTERIZATION OF VARIANT MDPT3 PRO-173</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Protein Sci." volume="19" first="168" last="173">
<title>High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligand.</title>
<authorList>
<person name="Cheng R."/>
<person name="Felicetti B."/>
<person name="Palan S."/>
<person name="Toogood-Johnson I."/>
<person name="Scheich C."/>
<person name="Barker J."/>
<person name="Whittaker M."/>
<person name="Hesterkamp T."/>
</authorList>
<dbReference type="PubMed" id="19937655"/>
<dbReference type="DOI" id="10.1002/pro.294"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 33-349 IN COMPLEX WITH INHIBITOR P4O</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Bioorg. Med. Chem. Lett." volume="21" first="3818" last="3822">
<title>Structure-based lead identification of ATP-competitive MK2 inhibitors.</title>
<authorList>
<person name="Barf T."/>
<person name="Kaptein A."/>
<person name="de Wilde S."/>
<person name="van der Heijden R."/>
<person name="van Someren R."/>
<person name="Demont D."/>
<person name="Schultz-Fademrecht C."/>
<person name="Versteegh J."/>
<person name="van Zeeland M."/>
<person name="Seegers N."/>
<person name="Kazemier B."/>
<person name="van de Kar B."/>
<person name="van Hoek M."/>
<person name="de Roos J."/>
<person name="Klop H."/>
<person name="Smeets R."/>
<person name="Hofstra C."/>
<person name="Hornberg J."/>
<person name="Oubrie A."/>
</authorList>
<dbReference type="PubMed" id="21565500"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2011.04.018"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 33-349 IN COMPLEX WITH INHIBITOR 5B</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] SER-28; ALA-105 AND TYR-276</scope>
</reference>
<comment type="function">
<text evidence="9 12 14 16 20 21">Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression.</text>
</comment>
<comment type="catalytic activity">
<text evidence="21">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text>Activated following phosphorylation by p38-alpha/MAPK14 following various stresses. Inhibited by ligand 5B (2'-[2-(1,3-benzodioxol-5-yl)pyrimidin-4-yl]-5',6'-dihydrospiro[piperidine-4,7'-pyrrolo[3,2-c]pyridin]- 4'(1'h)-one) and ligand P4O (2-[2-(2-fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro- 4h-pyrrolo[3,2-c]pyridin-4-one), 2 ATP-competitive inhibitors.</text>
</comment>
<comment type="subunit">
<text evidence="6 10 12 15 17">Heterodimer with p38-alpha/MAPK14. The heterodimer with p38-alpha/MAPK14 forms a stable complex: molecules are positioned 'face to face' so that the ATP-binding sites of both kinases are at the heterodimer interface (By similarity). Interacts with TCF3 and with polycomb proteins, such as PCH2 and BMI1/PCGF4.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1384657"/>
<interactant intactId="EBI-6377335">
<id>P27958</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1384657"/>
<interactant intactId="EBI-352682">
<id>P04792</id>
<label>HSPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1384657"/>
<interactant intactId="EBI-73946">
<id>Q16539</id>
<label>MAPK14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 18">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11 18">Cytoplasm</location>
</subcellularLocation>
<text>Predominantly located in the nucleus, when activated it translocates to the cytoplasm.</text>
</comment>
<comment type="tissue specificity">
<text evidence="18 19 20">Widely expressed, with a higher expression level observed in heart and skeletal muscle. No expression in brain. Expressed in the retinal pigment epithelium (PubMed:26744326).</text>
</comment>
<comment type="PTM">
<text evidence="6">Phosphorylated and activated by MAPK1/ERK2 and MAPK3/ERK1. Phosphorylated and activated by MAP kinase p38-alpha/MAPK14 at Thr-201, Ser-251 and Thr-313 (By similarity).</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-04818">
<name>Macular dystrophy, patterned, 3</name>
<acronym>MDPT3</acronym>
<description>A form of retinal patterned dystrophy, characterized by retinal pigment epithelium and Bruch's membrane changes resembling a 'dry desert land'. It begins around the age of 30 and progresses to retinitis pigmentosa. MDPT3 inheritance is autosomal dominant.</description>
<dbReference type="MIM" id="617111"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.</text>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="U43784">
<property type="protein sequence ID" value="AAC50428.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U09578">
<property type="protein sequence ID" value="AAD09136.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451303">
<property type="protein sequence ID" value="BAG70117.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW65131.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001662">
<property type="protein sequence ID" value="AAH01662.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007591">
<property type="protein sequence ID" value="AAH07591.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC010407">
<property type="protein sequence ID" value="AAH10407.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2832.1"/>
<dbReference type="PIR" id="JC6094">
<property type="entry name" value="JC6094"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001230854.1">
<property type="nucleotide sequence ID" value="NM_001243925.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001230855.1">
<property type="nucleotide sequence ID" value="NM_001243926.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004626.1">
<property type="nucleotide sequence ID" value="NM_004635.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.234521"/>
<dbReference type="UniGene" id="Hs.735013"/>
<dbReference type="PDB" id="3FHR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=33-349"/>
</dbReference>
<dbReference type="PDB" id="3FXW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=33-349"/>
</dbReference>
<dbReference type="PDB" id="3R1N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A=33-349"/>
</dbReference>
<dbReference type="PDB" id="3SHE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=33-349"/>
</dbReference>
<dbReference type="PDBsum" id="3FHR"/>
<dbReference type="PDBsum" id="3FXW"/>
<dbReference type="PDBsum" id="3R1N"/>
<dbReference type="PDBsum" id="3SHE"/>
<dbReference type="ProteinModelPortal" id="Q16644"/>
<dbReference type="SMR" id="Q16644"/>
<dbReference type="BioGrid" id="113617">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="IntAct" id="Q16644">
<property type="interactions" value="27"/>
</dbReference>
<dbReference type="MINT" id="MINT-3032958"/>
<dbReference type="STRING" id="9606.ENSP00000350639"/>
<dbReference type="BindingDB" id="Q16644"/>
<dbReference type="ChEMBL" id="CHEMBL4670"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2095"/>
<dbReference type="iPTMnet" id="Q16644"/>
<dbReference type="PhosphoSitePlus" id="Q16644"/>
<dbReference type="BioMuta" id="MAPKAPK3"/>
<dbReference type="DMDM" id="74762148"/>
<dbReference type="EPD" id="Q16644"/>
<dbReference type="MaxQB" id="Q16644"/>
<dbReference type="PaxDb" id="Q16644"/>
<dbReference type="PeptideAtlas" id="Q16644"/>
<dbReference type="PRIDE" id="Q16644"/>
<dbReference type="DNASU" id="7867"/>
<dbReference type="Ensembl" id="ENST00000357955">
<property type="protein sequence ID" value="ENSP00000350639"/>
<property type="gene ID" value="ENSG00000114738"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000446044">
<property type="protein sequence ID" value="ENSP00000396467"/>
<property type="gene ID" value="ENSG00000114738"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000621469">
<property type="protein sequence ID" value="ENSP00000478922"/>
<property type="gene ID" value="ENSG00000114738"/>
</dbReference>
<dbReference type="GeneID" id="7867"/>
<dbReference type="KEGG" id="hsa:7867"/>
<dbReference type="UCSC" id="uc003day.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7867"/>
<dbReference type="DisGeNET" id="7867"/>
<dbReference type="GeneCards" id="MAPKAPK3"/>
<dbReference type="HGNC" id="HGNC:6888">
<property type="gene designation" value="MAPKAPK3"/>
</dbReference>
<dbReference type="HPA" id="HPA058275"/>
<dbReference type="MIM" id="602130">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617111">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q16644"/>
<dbReference type="OpenTargets" id="ENSG00000114738"/>
<dbReference type="PharmGKB" id="PA30632"/>
<dbReference type="eggNOG" id="KOG0604">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XP8F">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00830000128274"/>
<dbReference type="HOGENOM" id="HOG000233031"/>
<dbReference type="HOVERGEN" id="HBG106948"/>
<dbReference type="InParanoid" id="Q16644"/>
<dbReference type="KO" id="K04444"/>
<dbReference type="OMA" id="SGCRHIV"/>
<dbReference type="OrthoDB" id="EOG091G14PL"/>
<dbReference type="PhylomeDB" id="Q16644"/>
<dbReference type="TreeFam" id="TF312891"/>
<dbReference type="Reactome" id="R-HSA-171007">
<property type="pathway name" value="p38MAPK events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559580">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450302">
<property type="pathway name" value="activated TAK1 mediates p38 MAPK activation"/>
</dbReference>
<dbReference type="SignaLink" id="Q16644"/>
<dbReference type="SIGNOR" id="Q16644"/>
<dbReference type="ChiTaRS" id="MAPKAPK3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q16644"/>
<dbReference type="GeneWiki" id="MAPKAPK3"/>
<dbReference type="GenomeRNAi" id="7867"/>
<dbReference type="PRO" id="PR:Q16644"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000114738"/>
<dbReference type="CleanEx" id="HS_MAPKAPK3"/>
<dbReference type="ExpressionAtlas" id="Q16644">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q16644">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0009931">
<property type="term" value="F:calcium-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004683">
<property type="term" value="F:calmodulin-dependent protein kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004708">
<property type="term" value="F:MAP kinase kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0044351">
<property type="term" value="P:macropinocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034097">
<property type="term" value="P:response to cytokine"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006950">
<property type="term" value="P:response to stress"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.1170.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027442">
<property type="entry name" value="MAPKAPK_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="MAP kinase-activated protein kinase 3" id="PRO_0000086293">
<location>
<begin position="1"/>
<end position="382"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="7">
<location>
<begin position="44"/>
<end position="304"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="7">
<location>
<begin position="50"/>
<end position="58"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory helix" evidence="6">
<location>
<begin position="307"/>
<end position="343"/>
</location>
</feature>
<feature type="region of interest" description="p38 MAPK-binding site" evidence="6">
<location>
<begin position="345"/>
<end position="369"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal (NES)" evidence="6">
<location>
<begin position="335"/>
<end position="344"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal 1" evidence="6">
<location>
<begin position="350"/>
<end position="353"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal 2" evidence="6">
<location>
<begin position="364"/>
<end position="368"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="7 8">
<location>
<position position="166"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="7">
<location>
<position position="73"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="4 5">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK14" evidence="6">
<location>
<position position="201"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK14" evidence="6">
<location>
<position position="251"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="6">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK14" evidence="6">
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioblastoma multiforme sample; somatic mutation." id="VAR_040755" evidence="13">
<original>P</original>
<variation>S</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian endometrioid sample; somatic mutation." id="VAR_040756" evidence="13">
<original>E</original>
<variation>A</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In MDPT3; decreased localization to the nucleus." id="VAR_077085" evidence="18">
<original>L</original>
<variation>P</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56107897." id="VAR_040757" evidence="13">
<original>D</original>
<variation>Y</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="mutagenesis site" description="Higher affinity toward PCH2." evidence="12">
<original>K</original>
<variation>M</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="39"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="43"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="56"/>
<end position="63"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="69"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="79"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="100"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="111"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="126"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="140"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="169"/>
<end position="171"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="172"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="218"/>
<end position="237"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="271"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="275"/>
<end position="284"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="295"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="302"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="307"/>
<end position="309"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="317"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="328"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="344"/>
<end position="346"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FHR"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3R1N"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SHE"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10383393"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10781029"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15302577"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15563468"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18021073"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19937655"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20599781"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21565500"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26744326"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8622688"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8626550"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8774846"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="382" mass="42987" checksum="405F958B7F54E6F3" modified="1996-11-01" version="1">
MDGETAEEQGGPVPPPVAPGGPGLGGAPGGRREPKKYAVTDDYQLSKQVLGLGVNGKVLE
CFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC
MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD
AVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP
PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN
HPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQVKIKDLKTSNNR
LLNKRRKKQAGSSSASQGCNNQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>